Home›Stocks›BBNX

BBNX — structural market context

Beta Bionics, Inc. Common Stoc

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

BBNX short interest & days to cover

SHARES SHORT
10.6M
% OF FLOAT
—
DAYS TO COVER
9.9
CHANGE VS PRIOR
+12.9%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-15 (23d ago)

BBNX fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-03 · 35d2K$19.42
2026-08-27 · 42d2K$19.34
2026-08-26 · 43d774$19.34

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

BBNX insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 13 sales

InsiderTypeSharesValueFiled
Hopman Mark · officer: Chief Commercial OfficerSell (S)370$7K2026-10-05
Jones Christy · directorSell (S)6K$148K2026-09-23
Hopman Mark · officer: Chief Commercial OfficerSell (S)36K$665K2026-09-18
Hopman Mark · officer: Chief Commercial OfficerSell (S)31K$620K2026-09-17
Mensinger Mike · officer: Chief Product OfficerSell (S)3K$58K2026-09-17

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

BBNX analyst ratings — with each firm's recent 5-session hit rate

FirmActionRatingFirm 5-session hit rate* (2026-09-23 – 2026-10-08)Published
Barclaysprice_target—n<302026-10-06
BarclaysinitialiseOverweightn<302026-10-06
Wells FargoinitialiseOverweight65.7% (n=35)2026-09-23
Wells Fargoprice_target—65.7% (n=35)2026-09-23
Truist Financialprice_target—n<302026-09-15

*Rating actions from public feeds. Where shown, the firm's hit rate is the share of its calls whose raw close-to-close return over the next 5 trading sessions moved in the call's direction, with no benchmark, over rating actions published between 2026-09-23 and 2026-10-08 (firms with >=30 graded calls). It describes those past calls; it does not grade this one.

Frequently asked questions

Are insiders buying BBNX?
In the last 12 months of SEC Form 4 filings, BBNX recorded 0 open-market insider purchases and 13 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about BBNX?
The most recent action: Barclays price_target on 2026-10-06. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell BBNX?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with B

BABA · Alibaba Group Holding LimitedBE · Bloom Energy CorporationBTI · British American Tobacco p.l.cBCDA · BioCardia, Inc.BELFB · Bel Fuse Inc.BFLY · Butterfly Network, Inc.All B →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.